Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9

被引:50
作者
Ashok, Anushruti [1 ,2 ]
Rai, Nagendra Kumar [1 ,2 ]
Raza, Waseem [2 ]
Pandey, Rukmani [1 ,2 ]
Bandyopadhyay, Sanghamitra [1 ,2 ]
机构
[1] Acad Sci & Innovat Res AcSIR, CSIR IITR Campus, Lucknow, Uttar Pradesh, India
[2] CSIR, Indian Inst Toxicol Res, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Vishvigyan Bhavan,31,Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India
关键词
BCCAO; HB-EGF; RAGE; LRP-1; BBB; AD; BLOOD-BRAIN-BARRIER; CAROTID-ARTERY OCCLUSION; FACTOR KNOCKOUT MICE; GROWTH-FACTOR; ALZHEIMERS-DISEASE; AMYLOID-BETA; RAT-BRAIN; MATRIX METALLOPROTEINASES; COGNITIVE IMPAIRMENT; RECEPTOR ACTIVATION;
D O I
10.1016/j.nbd.2016.07.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Chronic cerebral hypoperfusion (CCH) manifests Alzheimer's Disease (AD) neuropathology, marked by increased amyloid beta (A beta). Besides, hypoxia stimulates Heparin-binding EGF-like growth factor (HB-EGF) mRNA expression in the hippocampus. However, involvement of HB-EGF in CCH-induced A beta pathology remains unidentified. Here, using Bilateral Common Carotid Artery Occlusion mouse model, we explored the mechanism of HB-EGF regulated A beta induction in CCH. We found that HB-EGF inhibition suppressed, while exogenous-HB-EGF triggered hippocampal A beta, proving HB-EGF-dependent A beta increase. We also detected that HB-EGF affected the expression of primary A beta transporters, receptor for advanced glycation end-products (RAGE) and lipoprotein receptor-related protein-1 (LRP-1), indicating impaired A beta clearance across the blood-brain barrier (BBB). An HB-EGF-dependent loss in BBB integrity supported impaired A beta clearance. The effect of HB-EGF on Amyloid Precursor Protein pathway was relatively insignificant, suggesting a lesser effect on A beta generation. Delving into BBB disruption mechanism demonstrated HB-EGF-mediated stimulation of Matrix metalloprotease-9 (MMP9), which affected BBB via HB-EGF-ectodomain shedding and epidermal growth factor receptor activation. Examining the intersection of HB-EGF-regulated pathway and hypoxia revealed HB-EGF-dependent increase in transcription factor, Hypoxia-inducible factor-1alpha (HIF1 alpha.). Further, via binding to hypoxia-responsive elements in MMP9 gene, HIFI a stimulated MMP9 expression, and therefore appeared as a prominent intermediary in HB-EGF-induced BBB damage. Overall, our study reveals the essential role of HB-EGF in triggering CCH-mediated A beta accumulation. The proposed mechanism involves an HB-EGF-dependent HIF1 alpha increase, generating MMP9 that stimulates soluble-HB-EGF/EGFR-induced BBB disintegration. Consequently, CCH-mediated hippocampal RAGE and LRP-1 deregulation together with BBB damage impair A beta transport and clearance where HB-EGF plays a pivotal role. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:179 / 193
页数:15
相关论文
共 63 条
  • [1] [Anonymous], 2008, J VIS EXP
  • [2] Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
    Asakura, M
    Kitakaze, M
    Takashima, S
    Liao, Y
    Ishikura, F
    Yoshinaka, T
    Ohmoto, H
    Node, K
    Yoshino, K
    Ishiguro, H
    Asanuma, H
    Sanada, S
    Matsumura, Y
    Takeda, H
    Beppu, S
    Tada, M
    Hori, M
    Higashiyama, S
    [J]. NATURE MEDICINE, 2002, 8 (01) : 35 - 40
  • [3] Exposure to As-, Cd-, and Pb-Mixture Induces Aβ, Amyloidogenic APP Processing and Cognitive Impairments via Oxidative Stress-Dependent Neuroinflammation in Young Rats
    Ashok, Anushruti
    Rai, Nagendra Kumar
    Tripathi, Sachin
    Bandyopadhyay, Sanghamitra
    [J]. TOXICOLOGICAL SCIENCES, 2015, 143 (01) : 64 - 80
  • [4] Extracellular Matrix and Matrix Receptors in Blood-Brain Barrier Formation and Stroke
    Baeten, Kim M.
    Akassoglou, Katerina
    [J]. DEVELOPMENTAL NEUROBIOLOGY, 2011, 71 (11) : 1018 - 1039
  • [5] Interleukin-1α stimulates non-amyloidogenic pathway by α-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase
    Bandyopadhyay, Sanghamitra
    Hartley, Dean M.
    Cahill, Catherine M.
    Lahiri, Debomay K.
    Chattopadhyay, Naibedya
    Rogers, Jack T.
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2006, 84 (01) : 106 - 118
  • [6] Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
    Biron, Kaan E.
    Dickstein, Dara L.
    Gopaul, Rayshad
    Jefferies, Wilfred A.
    [J]. PLOS ONE, 2011, 6 (08):
  • [7] Upregulation of BACE1 and β-Amyloid Protein Mediated by Chronic Cerebral Hypoperfusion Contributes to Cognitive Impairment and Pathogenesis of Alzheimer's Disease
    Cai Zhiyou
    Yan Yong
    Sun Shanquan
    Zhang Jun
    Huang Liangguo
    Yan Ling
    Li Jieying
    [J]. NEUROCHEMICAL RESEARCH, 2009, 34 (07) : 1226 - 1235
  • [8] Matlnspector and beyond: promoter analysis based on transcription factor binding sites
    Cartharius, K
    Frech, K
    Grote, K
    Klocke, B
    Haltmeier, M
    Klingenhoff, A
    Frisch, M
    Bayerlein, M
    Werner, T
    [J]. BIOINFORMATICS, 2005, 21 (13) : 2933 - 2942
  • [9] Endophilin-1 regulates blood-brain barrier permeability via EGFR-JNK signaling pathway
    Chen, Lin
    Liu, Wenjing
    Wang, Ping
    Xue, Yixue
    Su, Qingjie
    Zeng, Chaosheng
    Shang, Xiuli
    [J]. BRAIN RESEARCH, 2015, 1606 : 44 - 53
  • [10] Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity
    Cockayne, Debra A.
    Cheng, Donavan T.
    Waschki, Benjamin
    Sridhar, Sriram
    Ravindran, Palanikumar
    Hilton, Holly
    Kourteva, Galina
    Bitter, Hans
    Pillai, Sreekumar G.
    Visvanathan, Sudha
    Mueller, Kai-Christian
    Holz, Olaf
    Magnussen, Helgo
    Watz, Henrik
    Fine, Jay S.
    [J]. PLOS ONE, 2012, 7 (06):